AKBA icon

Akebia Therapeutics
AKBA

Overview Fund Activity

76 hedge funds and large institutions have $58M invested in Akebia Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 10 closing their positions.

Holders
76
Holders Change
-3
Holders Change %
-3.8%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
19
Reduced
21
Closed
10
Calls
$1.61M
Puts
$276K
Net Calls
+$1.34M
Net Calls Change
+$646K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$3.48M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$856K
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$1.96M
4
Citigroup
4
Citigroup
New York
$174K
5
Bank of America
5
Bank of America
North Carolina
$255K

Top Sellers

1
Qube Research & Technologies (QRT)
1
Qube Research & Technologies (QRT)
United Kingdom
$138K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$8.57M
3
BlackRock
3
BlackRock
New York
$2.8M
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$8.23M
5
XT
5
XTX Topco
Cayman Islands
$158K
Name Holding Trade Value Shares
Change 		Shares
Change %
ASN
76
Advisory Services Network
Georgia
– -$24.7K -27,000 Closed
GCM
77
Graham Capital Management
Connecticut
– -$24.3K -26,586 Closed
Wolverine Trading
78
Wolverine Trading
Illinois
– -$18.7K -20,198 Closed
Goldman Sachs
79
Goldman Sachs
New York
– -$16.7K -18,273 Closed
GS
80
GTS Securities
New York
– -$16.1K -17,549 Closed
VWA
81
Visionary Wealth Advisors
Illinois
– -$13.6K -14,819 Closed
FHA
82
First Horizon Advisors
Tennessee
– -$5.12K -5,600 Closed
Citadel Advisors
83
Citadel Advisors
Florida
– -$883 -965 Closed
1 2 3
4